Americans for Safe Access

JUNE 2, 2020

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.

Clinical Trials 264

Clinical Trials DEA History Programs 264

Americans for Safe Access

NOVEMBER 3, 2024

TAKE A BREATH The Administrative Law Judge recently postponed the DEA’s highly anticipated rescheduling hearing and released the DEA’s witness list, prompting speculation, conspiracies, and anxiety about the delay and the agency’s next moves. Before you pull your hair out, read these five essential points to put your mind at ease.

DEA 299

DEA Law 299

NORML

DECEMBER 9, 2020

The reality that most high-schoolers have easier access to cannabis than do our nation’s top scientists is the height of absurdity and an indictment of the current system.”. “These common-sense regulatory changes are necessary and long overdue.

Access 246

Access Marijuana Clinical Trials Cannabis 246

Americans for Safe Access

JANUARY 15, 2025

DEA Postponed Rescheduling Hearing, What Just Happened? Join ASA staff as we dive into the new ruling to postpone the DEA hearings, what it means for the current rescheduling process, and where we go from here. SafeAccessNow.org

DEA 264

DEA 264

Americans for Safe Access

NOVEMBER 6, 2024

We will discuss the impacts of the election, a potentially jam-packed lame-duck session, National Days of Action, the DEA rescheduling hearings, and preparing for the 47th president & 119th Congress. Join ASA Staff, Advisors, Chapters, Members, & Affiliates for this post-election webinar. Add to Google Calendar Zoom Link: [link]

DEA 299

DEA 299

Veriheal

APRIL 25, 2024

One Arizona church, known as the Church of the Eagle and the Condor (CEC), recently settled a lawsuit with the Drug Enforcement Agency (DEA), the Department of Homeland Security (DHS), and other federal agencies. The DEA will also take samples of shipments to ensure that the only substance entering the country is ayahuasca.

DEA 111

DEA History Access Medicine 111

Cannabis Law Report

JUNE 3, 2021

A Seattle palliative care physician has filed a lawsuit against the DEA, contesting its decision to ban psilocybin for use by terminally ill patients. Background of the Case.

DEA 98

DEA Access Clinical Trials Patients 98

Americans for Safe Access

MARCH 12, 2025

While Schedule III may seem like a large deviation from the recommendations provided by HHS and DEA in 2016, outright dismissing the finding of HHS and DOJ, currently accepted medical use does not take into account the enormity of the scientific and medical discoveries that have happened in the time since they were issued as well as the vast societal (..)

DEA 130

DEA Policy Cannabis 130

Americans for Safe Access

APRIL 2, 2019

The Americans for Safe Access 2019 Unity Conference, themed The Price of Being a Medical Cannabis Patient, featured over a hundred patients from all over America visiting their representatives in Congress and the Senate to promote the Medical Cannabis Control Act of 2019.

Access 125

Access DEA Policy Patients 125

MJ Business Attorneys

JUNE 29, 2018

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

OCTOBER 21, 2019

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 104

DEA Cultivation Clinical Trials Policy 104

NORML

MARCH 1, 2019

” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue.

DEA 199

DEA Research and Development Clinical Trials Marijuana 199

Cannabis Law Report

AUGUST 12, 2021

Drug Enforcement Administration’s (DEA) refusal to accommodate state and federal right to try laws. US DEA , No. US DEA , No. RTT laws permit certain patients who have been diagnosed with life-threatening diseases or conditions access to investigational medications not yet approved for general use by the U.S.

DEA 105

DEA Medicine Food Patients 105

Veriheal

JUNE 22, 2021

Sue Sisley was quoted telling media, “there are thousands of different cannabis varieties that all have unique chemical profiles and produce unique clinical effects, but we didn’t have access to that normal diversity.” The post DEA Increases Access to Cannabis for Research Purposes appeared first on Cannabis Central.

DEA 66

DEA Access Therapy Cannabinoids 66

Americans for Safe Access

MAY 25, 2021

You will also find out how to access the recorded panels from Unity 2021 to catch anything you missed. Information on research steps from NIDA and DEA, House progress on SAFE Banking and other key bills, Developments in Alabama and Mississippi a call to action for veterans and a profile of ASA's 2021 Researcher of the Year, Philippe Lucas.

Research and Development 166

Research and Development DEA Banking Access 166

Cannabis Law Report

MARCH 10, 2021

Marijuana Moment reports A Seattle doctor hoping to expand access to psilocybin mushrooms for terminally ill cancer patients is taking… Read More. The post USA: Dr Suing DEA Over Right To Give Patients Psilocybin Treatment first appeared on Cannabis Law Report.

DEA 85

DEA Treatment Patients Access 85

Cannabis Law Report

MARCH 24, 2020

The DEA says the proposed rule will see additional registered growers and more diverse variety of marijuana strains available for research. Currently, the DEA has 37 pending applications to grow marijuana for research. DEA Publishes Notice of Proposed Rulemaking On Marijuana Research.

DEA 80

DEA Marijuana Extraction Strains 80

Cannabis Law Report

AUGUST 26, 2019

DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. percent delta-9 THC threshold, is not a controlled substance, and a DEA registration is not required to grow or research it.

DEA 59

DEA Access Marijuana Programs 59

Americans for Safe Access

JUNE 6, 2019

Drug Enforcement Administration (DEA) to reschedule cannabis, before filing suit. The plaintiffs appealed his decision.

DEA 230

DEA Patients Cannabis 230

Americans for Safe Access

JANUARY 12, 2024

ASA’s recommendation to FDA for scheduling can be found here.

DEA 130

DEA Media Access Data 130

MaxQ Cannabis

MAY 22, 2024

In a landmark decision, the Drug Enforcement Administration (DEA) recently announced the reclassification of cannabis from Schedule 1 to Schedule 3, marking a significant shift in the regulatory landscape surrounding this controversial plant.

DEA 111

DEA Banking Access Cannabis 111

Americans for Safe Access

NOVEMBER 17, 2017

For those unfamiliar with the story, Rhonda and her late husband Larry’s property in Washington State, near the town of Kettle Falls was raided in 2012 by the Drug Enforcement Administration (DEA) for growing medical cannabis.

DEA 184

DEA Marijuana Cannabis 184

Americans for Safe Access

OCTOBER 17, 2017

On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA).

Policy 184

Policy DEA Pharmaceutical Legislation 184

WeedAdvisor

AUGUST 28, 2019

Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Given the DEA’s stonewalling, forcing their hand is a notable achievement. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

Americans for Safe Access

NOVEMBER 29, 2024

The Notice of Proposed Rulemaking (NPRM) and the Drug Enforcement Administration's (DEA) General Notice of Hearing (GNoH) state : "The purpose of a hearing would be to receive factual evidence and expert opinion regarding whether marijuana should be transferred to Schedule III of the list of controlled substances.Upon reviewing the Notice of Proposed (..)

DEA 130

DEA Marijuana Legalization 130

SpeedWeed

MAY 24, 2021

The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.

DEA 52

DEA Cultivation Research and Development Marijuana 52

Veriheal

JANUARY 16, 2024

This occasion marks the first time that a federal agency has recommended rescheduling cannabis, and this could be the push the Drug Enforcement Administration (DEA) needs to finally make it happen. It may also result in federal legalization and easier access in states that have yet to legalize medicinal or recreational marijuana.

DEA 122

DEA Medicine Cannabis Legalization 122

NORML

JANUARY 15, 2020

Eleven states regulate the adult use of marijuana and 33 states provide for medical cannabis access. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). He continued: “The fact of the matter is that legalization and regulation work. Witnesses at today’s hearing were: Matthew J.

Policy 199

Policy DEA Legislation Data 199

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. Patients Are Not In This Alone.

Therapy 64

Therapy DEA Patients Clinical Trials 64

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

Cannabis Law Report

FEBRUARY 24, 2023

DEA extends many telemedicine flexibilities adopted during the COVID-19 PHE with appropriate safeguards WASHINGTON – Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 (..)

DEA 52

DEA Therapy Access Patients 52

Americans for Safe Access

SEPTEMBER 25, 2024

What's Inside For September 2024: DEA Hearing Delay on Cannabis Rescheduling Patients caught in the middle of CA Hemp Product Ban ASA releases What’s in Your Cannabis? Is your membership Current? Learn More about ASA Member Benefits & Join Today! A Patient & Consumer Guide to Navigating Cannabis Safety.

DEA 147

DEA Programs Patients Safety 147

WeedAdvisor

JUNE 1, 2019

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis.

DEA 55

DEA Marijuana History Cannabis 55

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. Countless veterans suffer from these ailments, and, as such, are pushing for access to as many treatments and therapies as possible.

DEA 104

DEA Chronic Pain Treatment Therapy 104

Cannabis Law Report

MARCH 30, 2022

NORML has long advocated for amending federal regulations so that federally-licensed scientists can directly access and assess the wide variety of cannabis products readily available in medical-use and adult-use state markets. The full text of S. 253 is online here. Additional information is available from NORML here.

Legislation 95

Legislation Clinical Trials DEA Access 95

Veriheal

DECEMBER 19, 2023

A new delta-8 study has revealed that people in states without access to legal cannabis products are far more likely to seek out and consume delta-8 and delta-9 variants, whether it be flower, edibles, or tinctures. To learn more about your access to medical cannabis or legal products, talk to one of our doctors today.

Legalization 115

Legalization Edibles DEA Access 115

Americans for Safe Access

JULY 22, 2024

Healthcare Experts & Cannabis Stakeholders Clear the Smoke on Cannabis Scheduling: Join a Physician, Pharmacist, Researcher, Caregiver, Veteran, Patients, and Patient Advocates as They Bring the Rescheduling Debate to Life Washington, DC – Public comment closes today on the Department of Justice’s (DOJ) proposed rule to move cannabis (marijuana) (..)

Media 130

Media DEA Patients Marijuana 130